Effects of Moclobemide on Event-related Potentials of Depressed Patients - A Preliminary Study

Hong Kong Journal of Psychiatry

Volumn 13, Issue 1, 2003, Pages 2-6+39

  Wang, J ^a   Zhang, M ^b   Lou, F ^c   Bian, Qian ^c   Chen, X ^c   Ogura, C ^a   Hiramatsu, K I ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Contingent negative variation; Depression; Event related potentials; Moclobemide; P300

Indexed keywords

MOCLOBEMIDE;

ADULT; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTINGENT NEGATIVE VARIATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG SAFETY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; LATENT PERIOD; MALE; REMISSION;

EID: 0346250010     PISSN: 10262121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Amrein R, Allen SR, Vranesic D, Stabl M. Antidepressant drug therapy: associate risks. J Neural Transm Suppl 1988;26:73-86.
2. Inoue T, Koyama T. Reversible inhibitor of MAO-A (RIMA). [In Japanese]. Nippon Rinsho 2001;59:1530-1534.
3. Amrein R, Stabl M, Henauer S, Affolter E, Jonkanski I. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic anti-depressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Can J Psychiatry 1997;42:1043-1050.
4. Monti JM. Effect of a reversible monoamine oxidase-A inhibitor (moclobemide) on sleep of depressed patients. Br J Psychiatry 1989;6(Suppl):61-65.
5. Sharpley AL, Cowen PJ. Effects of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98.
6. Roth WT, Duncan CC, Pfefferbaum A, Timsit-Berthier M. Application of cognitive ERPs in psychiatric patients. In: McCallum WC, Zappoli R, Denoth F, editors. Cerebral psychophysiology: study in event-related potentials. EEG Suppl 38. Amsterdam: Elsevier; 1986:419-438.
7. Heimberg DR, Naber G, Hemmeter U, et al. Contingent negative variation and attention in schizophrenic and depressed patients. Neuropsychobiology 1999;39:131-140.
8. Rohrbaugh JW, Gaillard AWK. Sensory and motor aspects of the contingent negative variation. In: Gaillard AWK, Ritter W, editors. Tutorials in ERP's research: endogenous components. Amsterdam: North Holland; 1983:269-310.
9. Brunia CHM. Movement and stimulus preceding negativity. Biol Psychol 1988;26:165-178.
10. Ogura C. Toward the promotion of clinical application of event-related potentials. In: Ogura C, Koga Y, Shimokoichi M, editors. Recent advances in event-related brain potential research. Amsterdam: Elsevier; 1996:1085-1088.
11. Anderer P, Saletu B, Semlitsh HS, Pascual-Marqui RD. Electrical sources of P300 event-related potentials revealed by low-resolution electromagnetic tomography. 2. Effects of neotropic therapy in age-associated memory impairment. Neuropsychobiology 1998;37:28-35.
12. Luthringer R, Dago KT, Pata A, et al. Pharmacoelectroencephalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects. Neuropsychobiology 1996;34:98-105.
13. Semlitsch HV, Anderer P, Saletu B, Binder GA, Decker KA. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects. Int Clin Psychopharmacol 1993;8:155-166.
14. Mayersohn M, Guentert TW. Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide. Clin Pharmacokinet 1995;29:292-332.
15. Hamilton M. Development of psychiatric rating scale for primary depression. Br J Soc Clin Psychol 1967;6:278-296.
16. Zhang MD, Wang JJ, Chen XS, Lou FY, Lian JH. An auditory P300 study of Chinese depressives - a preliminary study. Hong Kong J Psychiatry 1997;7:36-39.
17. Pfefferbaum A, Wenegrat B, Ford JM, Roth WT, Kopell BS. Clinical application of event-related potentials. II. Dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol 1984;59:104-124.
18. Their P, Axmann D, Gierdke GE. Slow brain potentials and psychomotor retardation in depression. Electroencephalogr Clin Neurophysiol 1986;63:570-581.
19. Giedke H, Heimann H, Rein W. Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline. Rev Electroencephalogr Neurophysiol Clin 1987;17:279-287.
20. El Massioui F, Lesevre N. Psychomotor retardation in depressed patients: an event-related study. Electroencephalogr Clin Neurophysiol 1988;70:46-55.
21. Bruder GE, Twoey JP, Stewart JW, Friedman D, Tenke C, Quitkin FM. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P300 latency. Biol Psychiatry 1991;30:233-246.
22. Ogura C, Nageishi Y, Omura F, et al. N200 component of event-related potentials in depression. Biol Psychiatry 1993;33:720-726.
23. Vandoolaeghe E, van-Hunsel F, Nuyten D, Maes M. Auditory event-related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J Affect Disord 1998;48:105-113.
24. Levit RA, Sutton S, Zubin J. Evoked potential correlates of information processing in psychiatric patients. Psychol Med 1973;3:487-494.
25. Gordon E, Kraiuhin C, Harris A, Meares R, Howson A. The differential diagnosis of dementia using P300 latency. Biol Psychiatry 1986;21:1123-1132.
26. Patterson JV, Michalewski HJ, Starr A. Latency variability of the components of auditory event-related potentials to infrequent stimuli in aging, Alzheimer-type dementia, and depression. Electroencephalogr Clin Neurophysiol 1988;71:450-460.
27. Santosh PJ, Malhorat S, Raghunathan M, Mehra YN. A study of P300 in melancholic depression: correlation with psychotic features. Biol Psychiatry 1994;35:474-479.
28. Ashton CH, Marshall EF, Marsh VR, Hassanyeh F, Wright-Honari S. Biological correlates of deliberate self-harm behaviour: a study of electrophalographic, biochemical and psychological variables in parasuicide. Acta Psychiatr Scand 1994;90:316-323.
29. Hansenne M, Pitchot W, Moreno AG, Zaldua IU, Ansseau M. Suicidal behavior in depressive disorder: an event-related potential study. Biol Psychiatry 1996;40:116-122.
30. Wang J, Chen X, Lou F. Event-related potentials and suicide behavior in patients with affective disorder. [In Chinese]. Zhonghua Yi Xue Za Zhi 2000;80:275-277.
31. Blackwood DH, Whalley LJ, Christie JE, Blackburn IM, St Clair DM, McInnes A. Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry 1987;150:154-160.
32. d'Ardhuy XL, Boeijinga PH, Renault B, et al. Effects of serotonin-selective and classical antidepressants on the auditory P300 cognitive potential. Neuropsychobiology 1999;40:207-213.
33. Takeshita S, Ogura C. Effect of D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value. Int J Psychophysiol 1994;16:99-106.
34. Nishimura N, Ogura C, Ohta H. Effects of the dopamine-related drug bromocriptine on event-related potentials and its relation to the law of initial value. Psychiatry Clin Neurosci 1995;49:79-86.
35. Urasaki M, Ogura C, Hirano K, Tomori K. Effects of the GABA mimetic drug, sodium valproate on event-related potentials and its relation to the law of initial value. Jpn J Psychiatry Neurol 1994;48:111-121.